Versant Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Versant Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.37K	Buy	+6	New	+$1.52K	﹤0.01%	2666

Other funds holding ASND

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Versant Capital Management's ASND Position: Q3 2026 in Review

Versant Capital Management opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 6 shares worth $1.37K. The stake represents ﹤0.01% of the portfolio and ranks #2666 among its holdings.

10 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Versant Capital Management held 6 shares of Ascendis Pharma A/S worth $1.37K as of Q3 2026.
Ascendis Pharma A/S was a new Versant Capital Management position in Q3 2026.
Ascendis Pharma A/S made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2666 holding.
10 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.